Is Convalescent Plasma Therapy Effective for Patients with Covid-19?

[1]  P. Dobesh,et al.  Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19 , 2020, Pharmacotherapy.

[2]  R. Bordet,et al.  Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19 , 2020, Circulation.

[3]  Shashank Srivastava,et al.  Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial) , 2020, medRxiv.

[4]  K. Subbarao,et al.  Convalescent plasma treatment for COVID‐19: Tempering expectations with the influenza experience , 2020, European journal of immunology.

[5]  M. M. van der Eerden,et al.  Convalescent Plasma for COVID-19. A randomized clinical trial , 2020, medRxiv.

[6]  L. Ren,et al.  Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. , 2020, JAMA.

[7]  Y. Shoenfeld,et al.  Convalescent plasma in Covid-19: Possible mechanisms of action , 2020, Autoimmunity Reviews.

[8]  Arturo Casadevall,et al.  The convalescent sera option for containing COVID-19. , 2020, The Journal of clinical investigation.

[9]  W. Lim,et al.  The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis , 2014, The Journal of infectious diseases.

[10]  M. A. Meledeo,et al.  Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease , 2020, Seminars in Hematology.